Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All remdesivir studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchRemdesivirRemdesivir (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Remdesivir for the treatment of COVID-19

Anseems et al., Cochrane Database of Systematic Reviews, doi:10.1002/14651858.CD014962
Aug 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Review of 5 RCTs prior to April 17, 2021 showing mortality RR 0.93 [0.81-1.06] for hospitalized patients.
Currently there are 70 remdesivir studies and meta analysis shows:
OutcomeImprovement
Mortality4% lower [-5‑12%]
Ventilation13% higher [-17‑55%]
ICU admission30% higher [12‑51%]
Hospitalization8% higher [-12‑33%]
Anseems et al., 5 Aug 2021, preprint, 10 authors.
This PaperRemdesivirAll
Remdesivir for the treatment of COVID-19
Kelly Ansems, Felicitas Grundeis, Karolina Dahms, Agata Mikolajewska, Volker Thieme, Vanessa Piechotta, Maria-Inti Metzendorf, Miriam Stegemann, Carina Benstoem, Falk Fichtner
Cochrane Database of Systematic Reviews, doi:10.1002/14651858.cd014962
Trusted evidence. Informed decisions. Better health.
Cochrane Library Trusted evidence. Informed decisions. Better health. Cochrane Database of Systematic Reviews Did patients get better with remdesivir? • Remdesivir may have little or no e ect on the length of time patients spent on invasive mechanical ventilation (2 studies, 1298 people). • We do not know whether remdesivir increases or decreases time on supplemental oxygen (3 studies, 1691 people). Did patients get worse with remdesivir? • We do not know whether patients are more or less likely to need any mechanical ventilation (invasive or non-invasive) with remdesivir (3 studies, 6696 people). • Patients may be less likely to need invasive mechanical ventilation (2 studies, 1159 people). • We do not know whether patients are more or less likely to need non-invasive mechanical ventilation (1 study, 573 people). • We do not know whether patients are more or less likely to need oxygen by mask or nasal prongs (1 study, 138 people) . Quality of life • None of the included studies reported quality of life. Unwanted e ects • We do not know whether remdesivir leads to more or fewer unwanted e ects of any level (3 studies, 1674 people) . • Patients are probably less likely to experience serious unwanted e ects with remdesivir than with placebo or standard care (3 studies, 1674 people) . In 1000 people, 63 fewer would experience a serious unwanted e ect compared to placebo or standard care. What are the limitations of the evidence? We are moderately confident in the..
References
Ader ; Ader, Er-Smadja, Poissy, Bouscambert-Duchamp, Belhadi et al., Antiviral drugs in hospitalised patients with COVID-19 -the DisCoVeRy trial, CLINICALTRIALS.GOV, doi:10.1101/2021.01.08.20248149
Beigel, Beigel, Tomashek, Dodd, Mehta et al., Remdesivir for the treatment of COVID-19 -final report, New England Journal of Medicine, doi:10.1056/NEJMoa2007764
Beigel, Tomashek, Dodd, Mehta, Zingman et al., Remdesivir for the treatment of COVID-19 -preliminary report, New England Journal of Medicine, doi:10.1056/NEJMoa2007764
Beigel, Tomashek, Dodd, Remdesivir for the treatment of COVID-19 -preliminary report, New England Journal of Medicine, doi:10.1056/NEJMc2022236
Deresinski, Treatment of COVID-19 patients with remdesivir, hydroxychloroquine, lopinavir, or interferon beta-1a
Elliott, Elliot, Chan, Deresinski 2020 {published data only} Deresinski S. Remdesivir and COVID-19
Epstein, Avoiding the termination of ACTT, doi:10.1093/eurheartj/ehaa546]EUCTR2020-001052-18-
Excel, Microso Corporation ; Moher ; Moher, Liberati, Tetzla, Altman et al., SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology, New England Journal of Medicine, doi:10.1371/journal.pmed.1000097
Eynde, Consortium. Repurposed antiviral drugs for COVID-19 -interim WHO solidarity trial results, New England Journal of Medicine, doi:10.3390/ph13050098
Funk, Pharris, Spiteri, Bundle, Melidou et al., Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021, Eurosurveillance, doi:10.2807/1560-7917.ES.2021.26.16.2100348
Galiuto, Patrono, Conflicting results on the e icacy of remdesivir in hospitalised COVID-19 patients: comment on the adaptive COVID-19 treatment trial, doi:10.1093/eurheartj/ehaa934]ISRCTN13035264
Gautret, Million, Jarrot, Jau, Colson et al., Natural history of COVID-19 and therapeutic options, Expert Review of Clinical Immunology, doi:10.1080/1744666X.2021.1847640
Goldberg, Zvi, Sheena, Sofer, Krause et al., A real-life setting evaluation of the e ect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel, doi:10.1056/NEJMoa2015301]ISRCTN15874265
Goldman, Goldman, Lye, Hui, Marks et al., Impact of baseline alanine aminotransferase levels on the safety and e icacy of remdesivir in severe COVID-19 patients
Grubaugh, Hanage, Rasmussen, Higgins, Thompson et al., Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear, doi:10.1016/j.cell.2020.06.040
Harrington, Baden, Hogan, A large, simple trial leading to complex questions, New England Journal of Medicine, doi:10.1056/NEJMe2034294]ISRCTN83971151
Hsu, Lai, Yen, Chen, Chen, E icacy of remdesivir in COVID-19 patients with a simulated twoarm controlled study, doi:10.1101/2020.05.02.20088559
Hu 2020 Hu, Song, Xu, Chen, Xu, Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China, Science China Life Sciences, doi:10.1007/s11427-020-1661-4
Huang 2020 Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, doi:10.1016/S0140-6736(20)30183-5
Kaka 2021 Kaka, Macdonnald, Greer, Vela, Duan-Porter et al., Major update: remdesivir for adults with COVID-19: a living systematic review and meta-analysis for the American College of Physicians Practice Points, Annals of Internal Medicine, doi:10.7326/L21-0130
Karagiannidis, Mostert, Hentschker, Voshaar, Malzahn et al., Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study, Cochrane Database of Systematic Reviews, doi:10.1016/S2213-2600(20)30316-7
Ko, Remdesivir reduces time to recovery in adults hospitalised with COVID-19: a meaningful step in therapeutic discovery, Journal of Clinical Outcomes Management, doi:10.1056/NEJMoa2007764]NCT04280705
Kupferschmidt, WHO's treatment megatrial is at a standstill, doi:10.1126/science.371.6533.972
Lai 2021 Lai, Chen, Wang, Chen, Wang et al., Clinical e icacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomised controlled trials, Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkab093
Li 2020b Li, Geng, Peng, Meng, Lu et al., Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Journal of Pharmaceutical Analysis, doi:10.1016/j.jpha.2020.03.001
Lo 2017 Lo, Jordan, Arvey, Sudhamsu, Shrivastava-Ranjan et al., GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses, Scientific Reports, doi:10.1038/srep43395
Malaiyan, Arumugam, Mohan, Malin ; Malin, Suárez et al., An update on the origin of SARS-CoV-2: despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues, Clinical Microbiology Reviews, doi:10.1002/jmv.26261
Mcguigan, Hassan-Abdallah, Srinivasan, Wang, Siddiqui et al., Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives, Journal of Medicinal Chemistry, doi:10.1021/jm060776w
Meng ; Meng, Xiong, He, Lin, Hao et al., CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China, Journal of Infection, doi:10.1016/j.jinf.2020.04.004
O N T R I B U T I O N S O F A U T H O R S Ka ; D E C L A R A T I O N S O F I N T E R, CB: methodological expertise and advice, data extraction and assessment, conception, writing and proofreading of the manuscript. FF: clinical expertise and advice, data extraction and assessment, conception, writing and proofreading of the manuscript
Olalla, Remdesivir for the treatment of COVID-19 -preliminary report, New England Journal of Medicine, doi:10.1056/NEJMc2022236
Olsen, Henriksen, Kåsine, Lund-Johansen, Hoel, Evaluation of remdesivir and hydroxychloroquine on viral clearance in COVID-19 patients: results from the NOR-solidarity randomised trial, CLINICALTRIALS.GOV, doi:10.2139/ssrn.3774182
Oran ; Oran, Topol, Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review, Annals of Internal Medicine, doi:10.7326/M20-3012
Paladugu, Donato, Remdesivir improved time to recovery in adults hospitalised with COVID-19 and lower respiratory tract involvement, Annals of Internal Medicine, doi:10.7326/ACPJ202007210-005
Pan 2020 Pan, Liu, Wang, Guo, Hao et al., Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study, Statistics in Medicine, doi:10.1001/jama.2020.6130
Pan, Peto, Karim, Alejandria, Henao-Restrepo et al., Repurposed antiviral drugs for COVID-19 -interim WHO solidarity trial results, CLINICALTRIALS.GOV, doi:10.1101/2020.10.15.20209817
Piechotta, Valk, Chai, Wood, Lamikanra et al., Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, doi:10.1371/journal.pone.0243705
Schilling, Lehfeld, Schumacher, Ullrich, Diercke et al., Disease severity of the first COVID-19 wave in Germany using reporting data from the national notification system, doi:10.25646/7170
Schwarz, Tober-Lau, Hillus, Helbig, Lippert et al., Comparative therapeutic e icacy of remdesivir and combination lopinavir, ritonavir and interferon beta against MERS-CoV, Science Translational Medicine, doi:10.3201/eid2708.211145
Siegel 2017 Siegel, Hui, Doer Ler, Chun, Zhang, Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the treatment of ebola and emerging viruses, Cochrane Database of Systematic Reviews, doi:10.1021/acs
{ 'indexed': {'date-parts': [[2024, 5, 14]], 'date-time': '2024-05-14T11:51:32Z', 'timestamp': 1715687492399}, 'reference-count': 204, 'publisher': 'Wiley', 'issue': '8', 'content-domain': {'domain': ['wiley.com', 'cochranelibrary.com'], 'crossmark-restriction': True}, 'DOI': '10.1002/14651858.cd014962', 'type': 'journal-article', 'created': {'date-parts': [[2021, 8, 5]], 'date-time': '2021-08-05T06:46:46Z', 'timestamp': 1628146006000}, 'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 64, 'title': 'Remdesivir for the treatment of COVID-19', 'prefix': '10.1002', 'volume': '2021', 'author': [ { 'given': 'Kelly', 'family': 'Ansems', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Intensive Care Medicine; Medical Faculty, RWTH ' 'Aachen University; Aachen Germany'}]}, { 'given': 'Felicitas', 'family': 'Grundeis', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Anaesthesiology and Intensive Care; University of ' 'Leipzig Medical Center; Leipzig Germany'}]}, { 'given': 'Karolina', 'family': 'Dahms', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Intensive Care Medicine; Medical Faculty, RWTH ' 'Aachen University; Aachen Germany'}]}, { 'given': 'Agata', 'family': 'Mikolajewska', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Infectious Diseases and Respiratory Medicine; ' 'Charité - Universitätsmedizin Berlin, corporate member of Freie ' 'Universität Berlin and Humboldt-Universität zu Berlin; Berlin ' 'Germany'}]}, { 'given': 'Volker', 'family': 'Thieme', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Anaesthesiology and Intensive Care; University of ' 'Leipzig Medical Center; Leipzig Germany'}]}, { 'given': 'Vanessa', 'family': 'Piechotta', 'sequence': 'additional', 'affiliation': [ { 'name': 'Cochrane Haematology, Department I of Internal Medicine, Center ' 'for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty ' 'of Medicine and University Hospital Cologne, University of ' 'Cologne; Cologne Germany'}]}, { 'given': 'Maria-Inti', 'family': 'Metzendorf', 'sequence': 'additional', 'affiliation': [ { 'name': 'Cochrane Metabolic and Endocrine Disorders Group; Institute of ' 'General Practice, Medical Faculty of the ' 'Heinrich-Heine-University Düsseldorf; Düsseldorf Germany'}]}, { 'given': 'Miriam', 'family': 'Stegemann', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Infectious Diseases and Respiratory Medicine; ' 'Charité - Universitätsmedizin Berlin, corporate member of Freie ' 'Universität Berlin and Humboldt-Universität zu Berlin; Berlin ' 'Germany'}]}, { 'given': 'Carina', 'family': 'Benstoem', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Intensive Care Medicine; Medical Faculty, RWTH ' 'Aachen University; Aachen Germany'}]}, { 'given': 'Falk', 'family': 'Fichtner', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Anaesthesiology and Intensive Care; University of ' 'Leipzig Medical Center; Leipzig Germany'}]}], 'member': '311', 'published-online': {'date-parts': [[2021, 8, 5]]}, 'reference': [ { 'key': '10.1002/14651858.CD014962-BIB0001|cit1', 'doi-asserted-by': 'publisher', 'first-page': '1813', 'DOI': '10.1056/NEJMoa2007764', 'article-title': 'Remdesivir for the treatment of COVID-19 - final report', 'volume': '383', 'year': '2020', 'journal-title': 'New\xa0England Journal of Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0002|cit2', 'unstructured': 'Beigel JH \xa0Dodd LE Remdesivir for the treatment of COVID-19 - ' 'preliminary report New England Journal of Medicine 10.1056/NEJMc2022236 ' '32649078'}, { 'key': '10.1002/14651858.CD014962-BIB0003|cit3', 'doi-asserted-by': 'publisher', 'first-page': '1813', 'DOI': '10.1056/NEJMoa2007764', 'article-title': 'Remdesivir for the treatment of COVID-19 - preliminary report', 'volume': '383', 'author': 'Beigel', 'year': '2020', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0004|cit4', 'doi-asserted-by': 'crossref', 'unstructured': 'Epstein M Avoiding the termination of ACTT European Heart Journal 2020 ' '10.1093/eurheartj/ehaa546', 'DOI': '10.1093/eurheartj/ehaa546'}, { 'key': '10.1002/14651858.CD014962-BIB0005|cit5', 'unstructured': 'A multicenter, adaptive, randomised blinded controlled trial of the ' 'safety and efficacy of investigational therapeutics for the treatment of ' 'COVID-19 in hospitalised adults - version for European Union/United ' 'Kingdom sites ' 'www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-001052-18-DE'}, { 'key': '10.1002/14651858.CD014962-BIB0006|cit6', 'unstructured': 'Conflicting results on the efficacy of remdesivir in hospitalised ' 'COVID-19 patients:\xa0comment on the adaptive COVID-19 treatment trial ' 'European Heart Journal 2020 10.1093/eurheartj/ehaa934'}, { 'key': '10.1002/14651858.CD014962-BIB0007|cit7', 'unstructured': 'Adaptive COVID-19 treatment trial in the EU & UK ' 'www.isrctn.com/ISRCTN13035264'}, { 'key': '10.1002/14651858.CD014962-BIB0008|cit8', 'unstructured': 'A multicenter, adaptive, randomised blinded controlled trial of the ' 'safety and efficacy of investigational therapeutics for the treatment of ' 'COVID-19 in hospitalised\xa0adults ' 'https://jrct.niph.go.jp/latest-detail/jRCT2031190264'}, { 'key': '10.1002/14651858.CD014962-BIB0009|cit9', 'doi-asserted-by': 'crossref', 'unstructured': 'Ko F Remdesivir\xa0reduces time to recovery in adults hospitalised\xa0' 'with COVID-19: a\xa0meaningful step in therapeutic discovery Journal of ' 'Clinical Outcomes Management 2020 10.1056/NEJMoa2007764', 'DOI': '10.12788/jcom.0010'}, { 'key': '10.1002/14651858.CD014962-BIB0010|cit10', 'unstructured': 'Adaptive COVID-19 treatment trial (ACTT) ' 'clinicaltrials.gov/ct2/show/NCT04280705'}, { 'key': '10.1002/14651858.CD014962-BIB0011|cit11', 'unstructured': 'Olalla J Remdesivir for the treatment of COVID-19 - preliminary report ' 'New England Journal of Medicine 10.1056/NEJMc2022236'}, { 'key': '10.1002/14651858.CD014962-BIB0012|cit12', 'doi-asserted-by': 'crossref', 'unstructured': 'Remdesivir improved time to recovery in adults hospitalised with ' 'COVID-19 and lower respiratory tract involvement Annals of Internal ' 'Medicine 2020 173 2 JC4 5 10.7326/ACPJ202007210-005 32687756', 'DOI': '10.7326/ACPJ202007210-005'}, { 'key': '10.1002/14651858.CD014962-BIB0013|cit13', 'doi-asserted-by': 'publisher', 'first-page': '41', 'DOI': '10.4103/ija.IJA_149_21', 'article-title': 'Clinical outcomes of using remdesivir in patients with moderate to ' 'severe COVID-19: a prospective randomised study', 'volume': '65', 'author': 'Mahajan', 'year': '2021', 'journal-title': 'Indian Journal of Anaesthesia'}, { 'key': '10.1002/14651858.CD014962-BIB0014|cit14', 'unstructured': 'This study will test a drug named remdesivir (GS-5734 TM ) to evaluate ' 'the safety and effectiveness of the drug in treating patients with ' 'moderate coronavirus disease 2019 (COVID-19) compared to standard of ' 'care treatment ' 'https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000842-32/ES'}, { 'key': '10.1002/14651858.CD014962-BIB0015|cit15', 'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir ' '(GS-5734™) in participants with moderate coronavirus disease (COVID-19) ' 'compared to standard of care treatment ' 'clinicaltrials.gov/ct2/show/results/NCT04292730'}, { 'issue': '11', 'key': '10.1002/14651858.CD014962-BIB0016|cit16', 'doi-asserted-by': 'publisher', 'first-page': '1048', 'DOI': '10.1001/jama.2020.16349', 'article-title': 'Effect of remdesivir vs standard care on clinical status at 11 days in ' 'patients with moderate COVID-19: a randomised clinical trial', 'volume': '324', 'author': 'Spinner', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1002/14651858.CD014962-BIB0017|cit17', 'unstructured': 'A trial of remdesivir in adults with severe COVID-19 ' 'clinicaltrials.gov/ct2/show/NCT04257656'}, { 'issue': '10236', 'key': '10.1002/14651858.CD014962-BIB0018|cit18', 'doi-asserted-by': 'publisher', 'first-page': '1569', 'DOI': '10.1016/s0140-6736(20)31022-9', 'article-title': 'Remdesivir in adults with severe COVID-19: a randomised, double-blind, ' 'placebo-controlled, multicentre trial', 'volume': '395', 'year': '2020', 'journal-title': 'The Lancet'}, { 'key': '10.1002/14651858.CD014962-BIB0019|cit19', 'unstructured': 'Wang Y Zhang D Du G Remdesivir in adults with severe COVID-19: a ' 'randomised, double-blind, placebo-controlled, multicentre trial Lancet ' '2020 395 10238 1569, poster'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0020|cit20', 'doi-asserted-by': 'publisher', 'first-page': '422', 'DOI': '10.1186/s13063-020-04352-9', 'article-title': 'Evaluation of the efficacy and safety of intravenous remdesivir in ' 'adult patients with severe COVID-19: study protocol for a phase 3 ' 'randomised, double-blind, placebo-controlled, multicentre trial', 'volume': '21', 'author': 'Wang', 'year': '2020', 'journal-title': 'Trials'}, { 'key': '10.1002/14651858.CD014962-BIB0021|cit21', 'doi-asserted-by': 'publisher', 'first-page': 'e041437', 'DOI': '10.1136/bmjopen-2020-041437', 'article-title': 'Protocol for the discovery trial: multicentre, adaptive, randomised ' 'trial of the safety and efficacy of treatments for COVID-19 in ' 'hospitalised adults', 'volume': '10', 'year': '2020', 'journal-title': 'BMJ Open'}, { 'key': '10.1002/14651858.CD014962-BIB0022|cit22', 'doi-asserted-by': 'publisher', 'DOI': '10.2139/ssrn.3774182', 'article-title': 'Evaluation of remdesivir and hydroxychloroquine on viral clearance in ' 'COVID-19 patients: results from the NOR-solidarity randomised trial ' '(preprint)', 'author': 'Barratt-Due', 'year': '2021', 'journal-title': 'SSRN'}, { 'key': '10.1002/14651858.CD014962-BIB0023|cit23', 'unstructured': 'A clinical trial to study the effects of additional treatments for ' 'patients hospitalised and receiving treatment due to COVID -19 ' 'www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42897'}, { 'key': '10.1002/14651858.CD014962-BIB0024|cit24', 'unstructured': 'Treatment of COVID-19 patients with remdesivir, hydroxychloroquine, ' 'lopinavir, or interferon beta-1a Infectious Disease Alert 2021 40 4'}, { 'key': '10.1002/14651858.CD014962-BIB0025|cit25', 'unstructured': 'Multi-centre, adaptive, randomised trial of the safety and efficacy of ' 'treatments of COVID-19 in hospitalised adults - discovery ' 'www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/FR'}, { 'key': '10.1002/14651858.CD014962-BIB0026|cit26', 'unstructured': 'Safety and efficacy of treatments of COVID-19 in hospitalised adults ' '(discovery) ' 'www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/PT'}, { 'key': '10.1002/14651858.CD014962-BIB0027|cit27', 'unstructured': 'A clinical study to evaluate the efficacy of different anti-viral drugs ' 'in SARS-CoV-2 infected patients (COVID-19) ' 'https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000982-18/NO'}, { 'key': '10.1002/14651858.CD014962-BIB0028|cit28', 'unstructured': 'An international randomised trial of additional treatments for COVID-19 ' 'in hospitalised patients who are all receiving the local standard of ' 'care www.clinicaltrialsregister.eu/ctr-search/trial/2020-001366-11/IT'}, { 'key': '10.1002/14651858.CD014962-BIB0029|cit29', 'unstructured': 'An international randomised trial of additional treatments for COVID-19 ' 'in hospitalised patients who are all receiving the local standard of ' 'care www.clinicaltrialsregister.eu/ctr-search/trial/2020-001366-11/LT'}, { 'key': '10.1002/14651858.CD014962-BIB0030|cit30', 'unstructured': 'An international randomised trial of additional treatments for COVID-19 ' 'in hospitalised patients who are all receiving the local standard of ' 'care - WHO-solidarity-Germany ' 'www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-001549-38-DE'}, { 'key': '10.1002/14651858.CD014962-BIB0031|cit31', 'doi-asserted-by': 'crossref', 'unstructured': 'Harrington DP Baden LR Hogan JW A large, simple trial leading to complex ' 'questions New England Journal of Medicine 2021 384 576 7 ' '10.1056/NEJMe2034294', 'DOI': '10.1056/NEJMe2034294'}, { 'key': '10.1002/14651858.CD014962-BIB0032|cit32', 'doi-asserted-by': 'crossref', 'unstructured': 'Public health emergency solidarity trial of treatments for COVID-19 ' 'infection in hospitalised patients www.isrctn.com/ISRCTN83971151 ' 'https://doi.org/10.1186/ISRCTN83971151', 'DOI': '10.1186/ISRCTN83971151'}, { 'issue': '6533', 'key': '10.1002/14651858.CD014962-BIB0033|cit33', 'doi-asserted-by': 'publisher', 'first-page': '972', 'DOI': '10.1126/science.371.6533.972', 'article-title': "WHO's treatment megatrial is at a standstill", 'volume': '371', 'author': 'Kupferschmidt', 'year': '2021', 'journal-title': 'Science'}, { 'key': '10.1002/14651858.CD014962-BIB0034|cit34', 'unstructured': 'An international randomised trial of additional treatments for COVID-19 ' 'in hospitalised patients who are all receiving the local standard of ' 'care https://lbctr.moph.gov.lb/Trials/Details/4522'}, { 'key': '10.1002/14651858.CD014962-BIB0035|cit35', 'unstructured': 'Trial of treatments for COVID-19 in hospitalised\xa0adults (discovery) ' 'clinicaltrials.gov/ct2/show/NCT04315948'}, { 'key': '10.1002/14651858.CD014962-BIB0036|cit36', 'unstructured': 'The efficacy of different anti-viral drugs in (severe acute respiratory ' 'syndrome-corona virus-2) SARS-CoV-2 ' 'clinicaltrials.gov/ct2/show/NCT04321616'}, { 'key': '10.1002/14651858.CD014962-BIB0037|cit37', 'unstructured': 'Treatments for COVID-19: Canadian arm of the solidarity trial ' 'clinicaltrials.gov/ct2/show/NCT04330690'}, { 'key': '10.1002/14651858.CD014962-BIB0038|cit38', 'unstructured': 'An international randomised trial of additional treatments for COVID-19 ' 'in hospitalised\xa0patients who are all receiving the local standard of ' 'care - WHO-solidarity-Germany clinicaltrials.gov/ct2/show/NCT04575064'}, { 'key': '10.1002/14651858.CD014962-BIB0039|cit39', 'unstructured': 'WHO COVID-19 solidarity trial for COVID-19 treatments ' 'clinicaltrials.gov/ct2/show/NCT04647669'}, { 'key': '10.1002/14651858.CD014962-BIB0040|cit40', 'doi-asserted-by': 'publisher', 'first-page': '2020.10.15.2020', 'DOI': '10.1101/2020.10.15.20209817', 'article-title': 'Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial ' 'results', 'author': 'Pan', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1002/14651858.CD014962-BIB0041|cit41', 'doi-asserted-by': 'crossref', 'unstructured': 'Vanden Eynde JJ COVID-19: an update about the discovery clinical trial ' 'Pharmaceuticals 2020 13 5 98 107 10.3390/ph13050098', 'DOI': '10.3390/ph13050098'}, { 'issue': '8', 'key': '10.1002/14651858.CD014962-BIB0042|cit42', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1056/NEJMoa2023184', 'article-title': 'Repurposed antiviral drugs for COVID-19 - interim WHO solidarity trial ' 'results', 'volume': '384', 'author': 'WHO Solidarity Trial Consortium', 'year': '2021', 'journal-title': 'New England Journal of Medicine'}, { 'issue': '9', 'key': '10.1002/14651858.CD014962-BIB0043|cit43', 'doi-asserted-by': 'publisher', 'first-page': 'e041437', 'DOI': '10.1136/bmjopen-2020-041437', 'article-title': 'Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised ' 'trial of the safety and efficacy of treatments for COVID-19 in ' 'hospitalised adults', 'volume': '10', 'author': 'Ader', 'year': '2020', 'journal-title': 'BMJ Open'}, { 'key': '10.1002/14651858.CD014962-BIB0044|cit44', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2021.01.08.20248149', 'article-title': 'Antiviral drugs in hospitalised patients with COVID-19 - the DisCoVeRy ' 'trial', 'author': 'Ader', 'year': '2021', 'journal-title': 'Medrxiv'}, { 'key': '10.1002/14651858.CD014962-BIB0045|cit45', 'doi-asserted-by': 'crossref', 'unstructured': 'Alpern JD Gertner E Off-label therapies for COVID-19 - are we all in ' 'this together? Clinical Pharmacology & Therapeutics 108 2 182 4', 'DOI': '10.1002/cpt.1862'}, { 'key': '10.1002/14651858.CD014962-BIB0046|cit46', 'article-title': 'Compassionate remdesivir treatment of severe COVID-19 pneumonia in ' 'intensive care unit (ICU) and non-ICU patients: clinical outcome and\xa0' 'differences in post-treatment hospitalisation status', 'volume': '158', 'author': 'Rech', 'year': '2020', 'journal-title': 'Pharmacological Research'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0047|cit47', 'doi-asserted-by': 'crossref', 'first-page': '18', 'DOI': '10.3126/jbs.v7i1.29849', 'article-title': 'COVID-19: recent advances in epidemiology, virology, etiopathogenesis, ' 'clinical trials and vaccine development', 'volume': '7', 'author': '\xa0Mohabeer', 'year': '2020', 'journal-title': 'Journal of Biomedical Sciences'}, { 'key': '10.1002/14651858.CD014962-BIB0048|cit48', 'unstructured': 'Drug to prevent lung injury secondary to COVID 19 ' 'www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=50026'}, { 'key': '10.1002/14651858.CD014962-BIB0049|cit49', 'unstructured': 'Remdesivir plus tocilizumab efficacy trial in moderate to severe ' 'COVID-19 patients ' 'www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49731'}, { 'issue': '10', 'key': '10.1002/14651858.CD014962-BIB0050|cit50', 'article-title': 'Remdesivir and COVID-19', 'volume': '39', 'author': 'Deresinski', 'year': '2020', 'journal-title': 'Infectious Disease Alert'}, { 'issue': '11', 'key': '10.1002/14651858.CD014962-BIB0051|cit51', 'article-title': 'Remdesivir\xa0injection', 'volume': '42', 'author': 'Elliott', 'year': '2020', 'journal-title': 'Internal Medicine Alert'}, { 'key': '10.1002/14651858.CD014962-BIB0052|cit52', 'unstructured': 'Elliot W Chan J Remdesivir\xa0injection and baricitinib\xa0tablets ' 'Internal Medicine Alert 2021'}, { 'key': '10.1002/14651858.CD014962-BIB0053|cit53', 'unstructured': 'A phase 3 randomised study to evaluate the safety and antiviral activity ' 'of remdesivir (GS-5734™) in participants with severe COVID-19 ' 'www.clinicaltrialsregister.eu/ctr-search/trial/2020-000841-15/ES'}, { 'key': '10.1002/14651858.CD014962-BIB0054|cit54', 'unstructured': 'Multi-centre, adaptive, randomised trial of the safety and efficacy of ' 'treatments of COVID-19 in hospitalised adults - DisCoVeRy ' 'www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000936-23'}, { 'key': '10.1002/14651858.CD014962-BIB0055|cit55', 'unstructured': 'A study to test a drug named remdesivir to evaluate the efficacy and ' 'safety of the drug in treating patients with COVID-19 in an outpatient ' 'setting (non-hospitalised) ' 'www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-003510-12-DK'}, { 'key': '10.1002/14651858.CD014962-BIB0056|cit56', 'unstructured': 'Clinical trial of remdesivir in COVID-19 patients'}, { 'key': '10.1002/14651858.CD014962-BIB0057|cit57', 'doi-asserted-by': 'crossref', 'first-page': '917.e1', 'DOI': '10.1016/j.cmi.2021.02.029', 'article-title': 'A real-life setting evaluation of the effect of remdesivir on viral ' 'load in COVID-19 patients admitted to a large tertiary centre in Israel', 'volume': '27', 'author': '\xa0Ben Zvi', 'year': '2021', 'journal-title': 'Clinical Microbiology and Infection'}, { 'key': '10.1002/14651858.CD014962-BIB0058|cit58', 'doi-asserted-by': 'publisher', 'first-page': '1827', 'DOI': '10.1056/NEJMoa2015301', 'article-title': 'Remdesivir for 5 or 10 days in patients with severe COVID-19', 'volume': '383', 'author': 'Goldman', 'year': '2020', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0059|cit59', 'unstructured': 'Study to assess the safety and effectiveness of remdesivir in people ' 'with severe COVID-19 www.isrctn.com/ISRCTN15874265'}, { 'key': '10.1002/14651858.CD014962-BIB0060|cit60', 'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir ' '(GS-5734™) in participants with severe coronavirus disease (COVID-19) ' 'clinicaltrials.gov/ct2/show/NCT04292899'}, { 'key': '10.1002/14651858.CD014962-BIB0061|cit61', 'first-page': '279A', 'article-title': 'Impact of baseline alanine aminotransferase levels on the safety and ' 'efficacy of remdesivir in severe COVID-19 patients', 'volume': '72', 'author': 'Goldman', 'year': '2020', 'journal-title': 'Hepatology'}, { 'key': '10.1002/14651858.CD014962-BIB0062|cit62', 'unstructured': 'Study to assess the safety and effectiveness of remdesivir in people ' 'with severe COVID-19 www.isrctn.com/ISRCTN15874265'}, { 'key': '10.1002/14651858.CD014962-BIB0063|cit63', 'unstructured': 'Study to assess the safety and effectiveness of remdesivir in people ' 'with moderate COVID-19 www.isrctn.com/ISRCTN85762140'}, { 'issue': '4', 'key': '10.1002/14651858.CD014962-BIB0064|cit64', 'doi-asserted-by': 'crossref', 'first-page': '1581', 'DOI': '10.3390/ijms22041581', 'article-title': 'Comparison of antiviral activity of gemcitabine with ' '2′-gluoro-2′-deoxycytidine and combination therapy with remdesivir ' 'against SARS-CoV-2', 'volume': '22', 'author': 'Jang', 'year': '2021', 'journal-title': 'International Journal of Molecular Sciences'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0065|cit65', 'article-title': 'Remdesivir\xa0injection and baricitinib\xa0tablets', 'volume': '43', 'author': 'Elliott', 'year': '2021', 'journal-title': 'Internal Medicine Alert'}, { 'issue': '9', 'key': '10.1002/14651858.CD014962-BIB0066|cit66', 'doi-asserted-by': 'publisher', 'first-page': '795', 'DOI': '10.1056/NEJMoa2031994', 'article-title': 'Baricitinib plus remdesivir for hospitalized\xa0adults with COVID-19', 'volume': '384', 'author': 'Kalil', 'year': '2020', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0067|cit67', 'unstructured': 'Adaptive COVID-19 treatment trial 2 (ACTT-2) ' 'clinicaltrials.gov/ct2/show/NCT04401579'}, { 'issue': '11', 'key': '10.1002/14651858.CD014962-BIB0068|cit68', 'article-title': 'Remdesivir\xa0use in patients requiring mechanical ventilation due to ' 'COVID-19', 'volume': '7', 'author': '\xa0Bernasconi', 'year': '2020', 'journal-title': 'Open Forum Infectious Diseases'}, { 'key': '10.1002/14651858.CD014962-BIB0069|cit69', 'unstructured': 'An international randomised trial of additional treatments for COVID-19 ' 'in hospitalised patients who are all receiving the local standard of ' 'care https://lbctr.moph.gov.lb/Trials/Details/4522'}, { 'key': '10.1002/14651858.CD014962-BIB0070|cit70', 'unstructured': 'Medical Brief Remdesivir for COVID-19 improves time to recovery - ' 'peer-reviewed adaptive COVID-19 teatment trial ' 'www.medicalbrief.co.za/archives/remdesivir-for-covid-19-improves-time-to-recovery-peer-reviewed-adaptive-covid-19-treatment-trial/ ' '2020 304'}, { 'key': '10.1002/14651858.CD014962-BIB0071|cit71', 'unstructured': 'A trial of remdesivir in adults with mild and moderate COVID-19 ' 'clinicaltrials.gov/ct2/show/NCT04252664'}, { 'key': '10.1002/14651858.CD014962-BIB0072|cit72', 'unstructured': 'Efficacy of a self-test and self-alert mobile applet in detecting ' 'susceptible infection of COVID-19 (COVID-19) ' 'clinicaltrials.gov/ct2/show/NCT04256395'}, { 'key': '10.1002/14651858.CD014962-BIB0073|cit73', 'unstructured': 'Adaptive COVID-19 treatment trial (ACTT) ' 'clinicaltrials.gov/ct2/show/NCT04280705'}, { 'key': '10.1002/14651858.CD014962-BIB0074|cit74', 'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir ' '(GS-5734™) in participants with severe coronavirus disease (COVID-19) ' 'clinicaltrials.gov/ct2/show/NCT04292899'}, { 'key': '10.1002/14651858.CD014962-BIB0075|cit75', 'unstructured': 'Expanded access remdesivir (RDV; GS-5734™) ' 'clinicaltrials.gov/ct2/show/NCT04302766'}, { 'key': '10.1002/14651858.CD014962-BIB0076|cit76', 'unstructured': 'Personalised\xa0health education against the health damage of novel ' 'coronavirus (COVID-19) outbreak in Hungary (PROACTIVE-19) ' 'clinicaltrials.gov/ct2/show/NCT04321928'}, { 'key': '10.1002/14651858.CD014962-BIB0077|cit77', 'unstructured': 'Expanded access treatment protocol: temdesivir (RDV; GS-5734) for the ' 'treatment of SARS-CoV2 (CoV) infection (COVID-19) ' 'clinicaltrials.gov/ct2/show/NCT04323761'}, { 'key': '10.1002/14651858.CD014962-BIB0078|cit78', 'unstructured': 'Stopping ACE-inhibitors in COVID-19 (ACEI-COVID) ' 'clinicaltrials.gov/ct2/show/record/NCT04353596?view=record'}, { 'key': '10.1002/14651858.CD014962-BIB0079|cit79', 'unstructured': 'Adaptive COVID-19 treatment trial 2 (ACTT-2) ' 'clinicaltrials.gov/ct2/show/NCT04401579'}, { 'key': '10.1002/14651858.CD014962-BIB0080|cit80', 'unstructured': 'A study to evaluate the efficacy and safety of remdesivir\xa0plus ' 'tocilizumab\xa0compared with remdesivir\xa0plus placebo in ' 'hospitalised\xa0participants with severe COVID-19 Pneumonia (REMDACTA) ' 'clinicaltrials.gov/ct2/show/NCT04409262'}, { 'key': '10.1002/14651858.CD014962-BIB0081|cit81', 'unstructured': 'Study of Merimepodib in combination with remdesivir in adult patients ' 'with advanced COVID-19 clinicaltrials.gov/ct2/show/NCT04410354'}, { 'key': '10.1002/14651858.CD014962-BIB0082|cit82', 'unstructured': 'Safety, tolerability and pharmacokinetics of inhaled nanoparticle ' 'formulation of remdesivir (GS-5734) and NA-831 ' 'clinicaltrials.gov/ct2/show/NCT04480333'}, { 'key': '10.1002/14651858.CD014962-BIB0083|cit83', 'unstructured': 'I-SPY COVID-19 trial: an adaptive platform trial for critically ill ' 'patients (I-SPY_COVID) clinicaltrials.gov/ct2/show/NCT04488081'}, { 'key': '10.1002/14651858.CD014962-BIB0084|cit84', 'unstructured': 'Adaptive COVID-19 treatment trial 3 (ACTT-3) ' 'clinicaltrials.gov/ct2/show/NCT04492475'}, { 'key': '10.1002/14651858.CD014962-BIB0085|cit85', 'unstructured': 'Study to evaluate the efficacy and safety of remdesivir (GS-5734™) ' 'treatment of coronavirus disease 2019 (COVID-19) in an outpatient ' 'setting clinicaltrials.gov/ct2/show/NCT04501952'}, { 'key': '10.1002/14651858.CD014962-BIB0086|cit86', 'unstructured': 'ACTIV-3: therapeutics for inpatients with COVID-19 (TICO) ' 'clinicaltrials.gov/ct2/show/NCT04501978'}, { 'key': '10.1002/14651858.CD014962-BIB0087|cit87', 'unstructured': 'Study in participants with early stage coronavirus disease 2019 ' '(COVID-19) to evaluate the safety, efficacy, and pharmacokinetics of ' 'remdesivir\xa0administered by inhalation ' 'clinicaltrials.gov/ct2/show/NCT04539262'}, { 'key': '10.1002/14651858.CD014962-BIB0088|cit88', 'unstructured': 'ACTIV-5 / big effect trial (BET-A) for the treatment of COVID-19 ' 'clinicaltrials.gov/ct2/show/NCT04583956'}, { 'key': '10.1002/14651858.CD014962-BIB0089|cit89', 'unstructured': 'ACTIV-5 / big effect trial (BET-B) for the treatment of COVID-19 ' 'clinicaltrials.gov/ct2/show/NCT04583969'}, { 'key': '10.1002/14651858.CD014962-BIB0090|cit90', 'unstructured': 'Adaptive COVID-19 treatment trial 4 (ACTT-4) ' 'clinicaltrials.gov/ct2/show/NCT04640168'}, { 'key': '10.1002/14651858.CD014962-BIB0091|cit91', 'unstructured': 'IFN-beta 1b and remdesivir for COVID19 ' 'clinicaltrials.gov/ct2/show/NCT04647695'}, { 'key': '10.1002/14651858.CD014962-BIB0092|cit92', 'unstructured': 'Efficacy and safety of remdesivir and tociluzumab for the management of ' 'severe COVID-19: a randomised controlled trial ' 'clinicaltrials.gov/ct2/show/NCT04678739'}, { 'key': '10.1002/14651858.CD014962-BIB0093|cit93', 'unstructured': 'Efficacy of remdisivir and Baricitinib for the treatment of severe COVID ' '19 patients clinicaltrials.gov/ct2/show/NCT04693026'}, { 'key': '10.1002/14651858.CD014962-BIB0094|cit94', 'unstructured': 'Efficacy and safety of DWJ1248 with remdesivir in severe COVID-19 ' 'patients clinicaltrials.gov/ct2/show/NCT04713176'}, { 'key': '10.1002/14651858.CD014962-BIB0095|cit95', 'unstructured': 'Remdesivir in adults with COVID-19: Mansoura\xa0university hospital ' 'experience clinicaltrials.gov/ct2/show/NCT04728880'}, { 'key': '10.1002/14651858.CD014962-BIB0096|cit96', 'unstructured': 'Study to evaluate the safety and antiviral activity of remdesivir ' '(GS-5734™) in participants with severe coronavirus disease (COVID-19) ' 'clinicaltrials.gov/ct2/show/NCT04292899'}, { 'key': '10.1002/14651858.CD014962-BIB0097|cit97', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciaa1041', 'article-title': 'Remdesivir for severe coronavirus disease 2019 (COVID- 19) versus a ' 'cohort receiving standard of care', 'volume': 'ciaa1041', 'author': '\xa0Perez', 'year': '2020', 'journal-title': 'Clinical Infectious Diseases'}, { 'key': '10.1002/14651858.CD014962-BIB0098|cit98', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1101/2020.10.15.20209817', 'article-title': 'Repurposed antiviral drugs for COVID-19 -interim WHO SOLIDARITY trial ' 'results', 'volume': '384', 'author': 'Pan', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1002/14651858.CD014962-BIB0099|cit99', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1056/NEJMoa2023184', 'article-title': 'Repurposed antiviral drugs for COVID-19 - Interim WHO solidarity trial ' 'results', 'volume': '384', 'author': 'Pan', 'year': '2021', 'journal-title': 'New England Journal of Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0100|cit100', 'doi-asserted-by': 'publisher', 'first-page': '62', 'DOI': '10.35772/ghm.2020.01106', 'article-title': 'Investigator initiated clinical trial of remdesivir for the treatment ' 'of COVID-19 in Japan', 'volume': '3', 'author': 'Saito', 'year': '2021', 'journal-title': 'Global Health & Medicine'}, { 'issue': '5', 'key': '10.1002/14651858.CD014962-BIB0101|cit101', 'doi-asserted-by': 'publisher', 'first-page': '1236', 'DOI': '10.1007/s43441-020-00159-7', 'article-title': 'Data monitoring for the Chinese clinical trials of remdesivir in ' 'treating patients with COVID-19 during the pandemic crisis', 'volume': '54', 'year': '2020', 'journal-title': 'Therapeutic Innovation & Regulatory Science'}, { 'key': '10.1002/14651858.CD014962-BIB0102|cit102', 'doi-asserted-by': 'publisher', 'first-page': '356', 'DOI': '10.17843/rpmesp.2020.372.5546', 'article-title': 'Rapid responses to the COVID-19 pandemic through science and global ' 'collaboration: the solidarity clinical trial', 'volume': '37', 'author': 'Soto', 'year': '2020', 'journal-title': 'Revista Peruana de Medicina Experimental y Salud Pública'}, { 'key': '10.1002/14651858.CD014962-BIB0103|cit103', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1208/s12248-020-00459-8', 'article-title': 'Remdesivir for treatment of COVID-19: combination of pulmonary and IV ' 'administration may offer additional\xa0benefit', 'volume': '22', 'author': 'Sun', 'year': '2020', 'journal-title': 'AAPS Journal'}, { 'issue': '13', 'key': '10.1002/14651858.CD014962-BIB0104|cit104', 'article-title': 'Early data on remdesivir for severe COVID-19: a promising start?', 'volume': '42', 'author': 'Tran', 'year': '2020', 'journal-title': 'Internal Medicine Alert'}, { 'key': '10.1002/14651858.CD014962-BIB0105|cit105', 'unstructured': 'A trial of remdesivir in adults with mild and moderate COVID-19 ' 'https://clinicaltrials.gov/ct2/show/NCT04252664'}, { 'key': '10.1002/14651858.CD014962-BIB0106|cit106', 'unstructured': 'Antiviral activity and safety of remdesivir in Bangladeshi patients with ' 'severe coronavirus disease (COVID-19) ' 'https://clinicaltrials.gov/ct2/show/NCT04596839'}, { 'key': '10.1002/14651858.CD014962-BIB0107|cit107', 'doi-asserted-by': 'publisher', 'first-page': '106272', 'DOI': '10.1016/j.cct.2021.106272', 'article-title': 'Remdesivir for the treatment of COVID-19: a systematic review and ' 'meta-analysis of randomised controlled trials', 'volume': '101', 'author': 'Al-Abdouh', 'year': '2021', 'journal-title': 'Contemporary Clinical Trials'}, { 'key': '10.1002/14651858.CD014962-BIB0108|cit108', 'doi-asserted-by': 'publisher', 'first-page': '606429', 'DOI': '10.3389/fmed.2020.606429', 'article-title': 'Mortality benefit of remdesivir in COVID-19: a systematic review and ' 'meta-analysis', 'volume': '7', 'author': 'Bansal', 'year': '2021', 'journal-title': 'Frontiers in Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0109|cit109', 'unstructured': 'Bhimraj A Morgan RL Shumaker AH Lavergne V Baden L Cheng VC IDSA ' 'guidelines on the treatment and management of patients with COVID-19 ' 'www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management'}, { 'issue': '9', 'key': '10.1002/14651858.CD014962-BIB0110|cit110', 'doi-asserted-by': 'publisher', 'first-page': 'e1003346', 'DOI': '10.1371/journal.pmed.1003346', 'article-title': 'Occurrence and transmission potential of asymptomatic and ' 'presymptomatic SARS-CoV-2 infections: a living systematic review and ' 'meta-analysis', 'volume': '17', 'author': 'Buitrago-Garcia', 'year': '2020', 'journal-title': 'PLoS Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0111|cit111', 'unstructured': 'Centers for Disease Control and Prevention COVIDView - a weekly ' 'surveillance summary of U.S. COVID-19 activity (Key updates for week 43) ' 'www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html'}, { 'key': '10.1002/14651858.CD014962-BIB0112|cit112', 'unstructured': 'German COVID-19 evidence-ecosystem www.covid-evidenz.de'}, { 'issue': '7', 'key': '10.1002/14651858.CD014962-BIB0113|cit113', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/14651858.CD013600.pub3', 'article-title': 'Convalescent plasma or hyperimmune immunoglobulin for people with ' 'COVID-19: a living systematic review', 'author': 'Chai', 'year': '2020', 'journal-title': 'Cochrane Database of Systematic Reviews'}, { 'issue': '4', 'key': '10.1002/14651858.CD014962-BIB0114|cit114', 'doi-asserted-by': 'publisher', 'first-page': '418', 'DOI': '10.1002/jmv.25681', 'article-title': 'Emerging coronaviruses: genome structure, replication, and pathogenesis', 'volume': '92', 'author': 'Chen', 'year': '2020', 'journal-title': 'Journal of Medical Virology'}, { 'key': '10.1002/14651858.CD014962-BIB0115|cit115', 'doi-asserted-by': 'publisher', 'first-page': 'm1091', 'DOI': '10.1136/bmj.m1091', 'article-title': 'Clinical characteristics of 113 deceased patients with coronavirus ' 'disease 2019: retrospective study', 'volume': '368', 'author': 'Chen', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1002/14651858.CD014962-BIB0116|cit116', 'doi-asserted-by': 'publisher', 'first-page': '104786', 'DOI': '10.1016/j.antiviral.2020.104786', 'article-title': 'Remdesivir, lopinavir, emetine, and homoharringtonine inhibit ' 'SARS-CoV-2 replication in vitro', 'volume': '178', 'author': 'Wong', 'year': '2020', 'journal-title': 'Antiviral Research'}, { 'key': '10.1002/14651858.CD014962-BIB0117|cit117', 'unstructured': 'Guidance for the production and publication of Cochrane living ' 'systematic reviews: Cochrane Reviews in living mode Available from ' 'community.cochrane.org/review-production/production-resources/living-systematic-reviews'}, { 'key': '10.1002/14651858.CD014962-BIB0118|cit118', 'unstructured': 'Core outcome set developers’ response to COVID-19 ' 'www.comet-initiative.org/Studies/Details/1538'}, { 'key': '10.1002/14651858.CD014962-BIB0119|cit119', 'unstructured': 'Veritas Health Innovation Covidence'}, { 'key': '10.1002/14651858.CD014962-BIB0120|cit120', 'unstructured': 'Remdesivir for the treatment of hospitalized adults COVID-19 patients ' '(part of German Ecosystem CEO-sys) ' 'www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021238065'}, { 'key': '10.1002/14651858.CD014962-BIB0121|cit121', 'volume-title': 'Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins ' 'JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). ' 'Cochrane Handbook for Systematic Reviews of Interventions version 6.2 ' '(updated February 2021).\xa0Available from trai', 'author': 'Deeks', 'year': '2020'}, { 'issue': '12', 'key': '10.1002/14651858.CD014962-BIB0122|cit122', 'doi-asserted-by': 'publisher', 'first-page': '6771', 'DOI': '10.1073/pnas.1922083117', 'article-title': 'Prophylactic and therapeutic remdesivir (GS5734) treatment in the ' 'rhesus macaque model of MERS-CoV infection', 'volume': '117', 'author': 'Wit', 'year': '2020', 'journal-title': 'Proceedings of the National Academy of Sciences'}, { 'key': '10.1002/14651858.CD014962-BIB0123|cit123', 'unstructured': 'Eldridge S Campbell M Campbell M Dahota A Giraudeau B Higgins JT Revised ' 'Cochrane risk of bias tool for randomized trials (RoB 2.0). Additional ' 'considerations for cluster-randomized trials ' 'www.riskofbias.info/welcome/rob-2-0-tool/rob-2-for-cluster-randomized-trials'}, { 'issue': '4', 'key': '10.1002/14651858.CD014962-BIB0124|cit124', 'doi-asserted-by': 'publisher', 'first-page': 'e2187', 'DOI': '10.1002/rmv.2187', 'article-title': 'Efficacy and safety of remdesivir in hospitalised COVID-19 patients: ' 'systematic review and meta-analysis including network meta-analysis', 'volume': '31', 'author': 'Elsawah', 'year': '2021', 'journal-title': 'Reviews in Medical Virology'}, { 'key': '10.1002/14651858.CD014962-BIB0125|cit125', 'unstructured': 'European Medicines Agency Summary on compassionate use remdesivir Gilead ' 'www.ema.europa.eu/en/documents/other/summary-compassionate-use-remdesivir-gilead_en.pdf'}, { 'key': '10.1002/14651858.CD014962-BIB0126|cit126', 'unstructured': 'European Commission authorises first treatment against COVID-19 ' 'eeas.europa.eu/headquarters/headquarters-homepage/82135'}, { 'key': '10.1002/14651858.CD014962-BIB0127|cit127', 'unstructured': 'Fact sheet for health care providers Emergency Use Authorisazation (EUA) ' 'of remdesivir (GS-5734™) ' 'www.askgileadmedical.com/downloads/pdfs/EUA%20Fact%20Sheet%20for%20HCPs.pdf'}, { 'issue': '16', 'key': '10.1002/14651858.CD014962-BIB0128|cit128', 'doi-asserted-by': 'publisher', 'DOI': '10.2807/1560-7917.ES.2021.26.16.2100348', 'article-title': 'Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or ' 'P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021', 'volume': '26', 'author': 'Funk', 'year': '2021', 'journal-title': 'Eurosurveillance'}, { 'issue': '12', 'key': '10.1002/14651858.CD014962-BIB0129|cit129', 'doi-asserted-by': 'publisher', 'first-page': '1159', 'DOI': '10.1080/1744666X.2021.1847640', 'article-title': 'Natural history of COVID-19 and therapeutic options', 'volume': '16', 'author': 'Million', 'year': '2020', 'journal-title': 'Expert Review of Clinical Immunology'}, { 'issue': '4', 'key': '10.1002/14651858.CD014962-BIB0130|cit130', 'doi-asserted-by': 'publisher', 'first-page': '794', 'DOI': '10.1016/j.cell.2020.06.040', 'article-title': 'Making sense of mutation: what D614G means for the COVID-19 pandemic ' 'remains unclear', 'volume': '182', 'author': 'Rasmussen', 'year': '2020', 'journal-title': 'Cell'}, { 'key': '10.1002/14651858.CD014962-BIB0131|cit131', 'doi-asserted-by': 'publisher', 'first-page': '557', 'DOI': '10.1136/bmj.327.7414.557', 'article-title': 'Measuring inconsistency in metaanalyses', 'volume': '327', 'author': 'Higgins', 'year': '2003', 'journal-title': 'BMJ'}, { 'key': '10.1002/14651858.CD014962-BIB0132|cit132', 'unstructured': 'Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA ' 'Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 ' '(updated February 2021). Cochrane, 2021 Available from ' 'training.cochrane.org/handbook'}, { 'key': '10.1002/14651858.CD014962-BIB0133|cit133', 'unstructured': 'Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized ' 'trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, ' 'Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of ' 'Interventions Version 6.2 (updated February 2021). Cochrane, 2021 ' 'Available from training.cochrane.org/handbook'}, { 'key': '10.1002/14651858.CD014962-BIB0134|cit134', 'unstructured': 'Higgins JP Savović J Page MJ Elbers RG Sterne JA Chapter 8: Assessing ' 'risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler ' 'J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for ' 'Systematic Reviews of Interventions Version 6.2 (updated February 2021). ' 'Cochrane, 2021 Available from training.cochrane.org/handbook'}, { 'key': '10.1002/14651858.CD014962-BIB0135|cit135', 'unstructured': 'Higgins JP Tianging L Deeks JJ Chapter 6: Choosing effect measures and ' 'computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, ' 'Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for ' 'Systematic Reviews of Interventions Version 6.2 (updated February 2021). ' 'Cochrane, 2021 Available from training.cochrane.org/handbook'}, { 'key': '10.1002/14651858.CD014962-BIB0136|cit136', 'doi-asserted-by': 'crossref', 'unstructured': 'Hsu CY Lai CC Yen AMF Chen SLS Chen HH Efficacy of remdesivir in ' 'COVID-19 patients with a simulated two-arm controlled study (preprint) ' 'medRxiv 2021 10.1101/2020.05.02.20088559', 'DOI': '10.1101/2020.05.02.20088559'}, { 'key': '10.1002/14651858.CD014962-BIB0137|cit137', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s11427-020-1661-4', 'article-title': 'Clinical characteristics of 24 asymptomatic infections with COVID-19 ' 'screened among close contacts in Nanjing, China', 'volume': '63', 'author': 'Hu', 'year': '2020', 'journal-title': 'Science China Life Sciences'}, { 'issue': '10223', 'key': '10.1002/14651858.CD014962-BIB0138|cit138', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'article-title': 'Clinical features of patients infected with 2019 novel coronavirus in ' 'Wuhan, China', 'volume': '395', 'author': 'Huang', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1002/14651858.CD014962-BIB0139|cit139', 'doi-asserted-by': 'publisher', 'DOI': '10.7326/M20-8148', 'article-title': 'Major update: remdesivir for adults with COVID-19: a living systematic ' 'review and meta-analysis for the American College of Physicians ' 'Practice Points', 'volume': '2021', 'author': 'Kaka', 'year': '2021', 'journal-title': 'Annals of Internal Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0140|cit140', 'doi-asserted-by': 'crossref', 'first-page': '853', 'DOI': '10.1016/S2213-2600(20)30316-7', 'article-title': 'Case characteristics, resource use, and outcomes of 10 021 patients ' 'with COVID-19 admitted to 920 German hospitals: an observational study', 'volume': '8', 'author': 'Karagiannidis', 'year': '2020', 'journal-title': 'Lancet Respiratory Medicine'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0141|cit141', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/14651858.CD013825', 'article-title': 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19', 'author': 'Hirsch', 'year': '2021', 'journal-title': 'Cochrane Database of Systematic Reviews'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0142|cit142', 'doi-asserted-by': 'publisher', 'first-page': '13', 'DOI': '10.1007/s13337-020-00571-5', 'article-title': 'Structural, glycosylation and antigenic variation between 2019 novel ' 'coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)', 'volume': '31', 'author': 'Kumar', 'year': '2020', 'journal-title': 'VirusDisease'}, { 'key': '10.1002/14651858.CD014962-BIB0143|cit143', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/jac/dkab093', 'article-title': 'Clinical efficacy and safety of remdesivir in patients with COVID-19: a ' 'systematic review and network meta-analysis of randomised controlled ' 'trials', 'author': 'Lai', 'year': '2021', 'journal-title': 'Journal of Antimicrobial Chemotherapy'}, { 'issue': '9', 'key': '10.1002/14651858.CD014962-BIB0144|cit144', 'doi-asserted-by': 'publisher', 'first-page': '577-82', 'DOI': '10.7326/M20-0504', 'article-title': 'The incubation period of coronavirus disease 2019 (COVID-19) from ' 'publicly reported confirmed cases: estimation and application', 'volume': '172', 'author': 'Lauer', 'year': '2020', 'journal-title': 'Annals of Internal Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0145|cit145', 'unstructured': 'Li T Higgins JP Deeks JJ Cochrane Handbook for Systematic Reviews of ' 'Interventions Version 6.2.\xa0(updated February 2021). Cochrane, 2020. ' 'Available from training.cochrane.org/handbook'}, { 'issue': '2', 'key': '10.1002/14651858.CD014962-BIB0146|cit146', 'doi-asserted-by': 'publisher', 'first-page': '102', 'DOI': '10.1016/j.jpha.2020.03.001', 'article-title': 'Molecular immune pathogenesis and diagnosis of COVID-19', 'volume': '10', 'author': 'Li', 'year': '2020', 'journal-title': 'Journal of Pharmaceutical Analysis'}, { 'issue': '3', 'key': '10.1002/14651858.CD014962-BIB0147|cit147', 'doi-asserted-by': 'publisher', 'first-page': '335', 'DOI': '10.1016/S1470-2045(20)30096-6', 'article-title': 'Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China', 'volume': '21', 'author': 'Liang', 'year': '2020', 'journal-title': 'Lancet Oncology'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0148|cit148', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1038/srep43395.', 'article-title': 'GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and ' 'Paramyxoviruses', 'volume': '7', 'author': 'Lo', 'year': '2017', 'journal-title': 'Scientific Reports'}, { 'issue': '11', 'key': '10.1002/14651858.CD014962-BIB0149|cit149', 'doi-asserted-by': 'publisher', 'first-page': '1203', 'DOI': '10.3390/v12111203', 'article-title': 'Viewpoint: origin of SARS-CoV-2', 'volume': '12', 'author': 'Lundstrom', 'year': '2020', 'journal-title': 'Viruses'}, { 'key': '10.1002/14651858.CD014962-BIB0150|cit150', 'unstructured': 'Norwegian MAGIC Evidence Ecosystem Foundation\xa0(powered by UserVoice ' 'Inc.) MAGICapp'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0151|cit151', 'doi-asserted-by': 'publisher', 'first-page': '499', 'DOI': '10.1002/jmv.26261', 'article-title': 'An update on the origin of SARS-CoV-2: despite closest identity, bat ' '(RaTG13) and pangolin derived coronaviruses varied in the critical ' 'binding site and O-linked glycan residues', 'volume': '93', 'author': 'Malaiyan', 'year': '2020', 'journal-title': 'Journal of Medical Virology'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0152|cit152', 'doi-asserted-by': 'publisher', 'first-page': 'e00162', 'DOI': '10.1128/CMR.00162-20', 'article-title': 'Remdesivir against COVID-19 and other viral diseases', 'volume': '34', 'author': 'Malin', 'year': '2020', 'journal-title': 'Clinical Microbiology Reviews'}, { 'issue': '24', 'key': '10.1002/14651858.CD014962-BIB0153|cit153', 'doi-asserted-by': 'publisher', 'first-page': '7215', 'DOI': '10.1021/jm060776w.', 'article-title': 'Application of phosphoramidate ProTide technology significantly ' 'improves antiviral potency of carbocyclic adenosine derivatives', 'volume': '49', 'author': 'McGuigan', 'year': '2006', 'journal-title': 'Journal of Medicinal Chemistry'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0154|cit154', 'doi-asserted-by': 'publisher', 'first-page': 'e33', 'DOI': '10.1016/j.jinf.2020.04.004', 'article-title': 'CT imaging and clinical course of asymptomatic cases with COVID-19 ' 'pneumonia at admission in Wuhan, China', 'volume': '81', 'author': 'Meng', 'year': '2020', 'journal-title': 'Journal of Infection'}, { 'key': '10.1002/14651858.CD014962-BIB0155|cit155', 'unstructured': 'Mircosoft Excel Microsoft Corporation 2018'}, { 'issue': '7', 'key': '10.1002/14651858.CD014962-BIB0156|cit156', 'doi-asserted-by': 'publisher', 'first-page': 'e1000097', 'DOI': '10.1371/journal.pmed.1000097', 'article-title': 'Preferred reporting items for systematic reviews and meta-analyses: the ' 'PRISMA statement', 'volume': '6', 'author': 'Moher', 'year': '2009', 'journal-title': 'PLOS Medicine'}, { 'issue': '24', 'key': '10.1002/14651858.CD014962-BIB0157|cit157', 'doi-asserted-by': 'publisher', 'first-page': '2293', 'DOI': '10.1056/NEJMoa1910993', 'article-title': 'A randomised, controlled trial of Ebola virus disease therapeutics', 'volume': '381', 'author': 'Mulangu', 'year': '2019', 'journal-title': 'New England Journal of Medicine'}, { 'issue': '9', 'key': '10.1002/14651858.CD014962-BIB0158|cit158', 'doi-asserted-by': 'publisher', 'first-page': '925', 'DOI': '10.1099/jgv.0.001453', 'article-title': 'SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, ' 'rapid adaptation and cytopathology', 'volume': '101', 'author': 'Dalebout', 'year': '2020', 'journal-title': 'Journal of General Virology'}, { 'issue': '5', 'key': '10.1002/14651858.CD014962-BIB0159|cit159', 'doi-asserted-by': 'publisher', 'first-page': '362', 'DOI': '10.7326/M20-3012', 'article-title': 'Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review', 'volume': '173', 'author': 'Oran', 'year': '2020', 'journal-title': 'Annals of Internal Medicine'}, { 'issue': '19', 'key': '10.1002/14651858.CD014962-BIB0160|cit160', 'doi-asserted-by': 'publisher', 'first-page': '1915', 'DOI': '10.1001/jama.2020.6130', 'article-title': 'Association of public health interventions with the epidemiology of the ' 'COVID-19 outbreak in Wuhan, China', 'volume': '323', 'author': 'Pan', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '24', 'key': '10.1002/14651858.CD014962-BIB0161|cit161', 'doi-asserted-by': 'publisher', 'first-page': '2815', 'DOI': '10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8', 'article-title': 'Extracting summary statistics to perform metaanalyses of the published ' 'literature for survival endpoints', 'volume': '17', 'author': 'Parmar', 'year': '1998', 'journal-title': 'Statistics in Medicine'}, { 'key': '10.1002/14651858.CD014962-BIB0162|cit162', 'doi-asserted-by': 'publisher', 'first-page': 'm1966', 'DOI': '10.1136/bmj.m1966', 'article-title': 'Factors associated with hospital admission and critical illness among ' '5279 people with coronavirus disease 2019 in New York City: prospective ' 'cohort study', 'volume': '369', 'author': 'Petrilli', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1002/14651858.CD014962-BIB0163|cit163', 'doi-asserted-by': 'publisher', 'DOI': '10.17605/OSF.IO/DWF53', 'article-title': 'Safety and effectiveness of convalescent plasma or\xa0hyperimmune ' 'globulin for people with COVID-19: a rapid\xa0review', 'author': 'Piechotta', 'year': '2020', 'journal-title': 'OSF Registries'}, { 'issue': '12', 'key': '10.1002/14651858.CD014962-BIB0164|cit164', 'doi-asserted-by': 'publisher', 'first-page': 'e0243705', 'DOI': '10.1371/journal.pone.0243705', 'article-title': 'Efficacy and harms of remdesivir for the treatment of COVID-19: a ' 'systematic review and meta-analysis', 'volume': '15', 'author': 'Piscoya', 'year': '2020', 'journal-title': 'PLOS ONE'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0165|cit165', 'doi-asserted-by': 'publisher', 'first-page': '389', 'DOI': '10.25646/7111', 'article-title': 'A higher mortality rate and long ventilation times differentiate ' 'COVID-19 from severe respiratory infections in flu waves', 'volume': '24', 'author': 'Potere', 'year': '2020', 'journal-title': 'Critical Care'}, { 'key': '10.1002/14651858.CD014962-BIB0166|cit166', 'unstructured': 'The Cochrane Collaboration Review Manager Web (RevMan Web) 2021'}, { 'issue': '20', 'key': '10.1002/14651858.CD014962-BIB0167|cit167', 'doi-asserted-by': 'publisher', 'first-page': '2052', 'DOI': '10.1001/jama.2020.6775', 'article-title': 'Presenting characteristics, comorbidities, and outcomes among 5700 ' 'patients hospitalized with COVID-19 in the New York City area', 'volume': '323', 'author': 'Richardson', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '5', 'key': '10.1002/14651858.CD014962-BIB0168|cit168', 'first-page': '376', 'article-title': 'The efficacy of remdesivir in coronavirus disease 2019 (COVID-19): a ' 'systematic review', 'volume': '12', 'author': 'Roshanshad', 'year': '2020', 'journal-title': 'Iranian Journal of Microbiology'}, { 'key': '10.1002/14651858.CD014962-BIB0169|cit169', 'doi-asserted-by': 'publisher', 'first-page': '126', 'DOI': '10.1016/j.jclinepi.2019.10.014', 'article-title': 'GRADE guidelines 26: informative statements to communicate the findings ' 'of systematic reviews of interventions', 'volume': '119', 'author': 'Santesso', 'year': '2020', 'journal-title': 'Journal of Clinical Epidemiology'}, { 'issue': 'S11', 'key': '10.1002/14651858.CD014962-BIB0170|cit170', 'doi-asserted-by': 'publisher', 'first-page': '2', 'DOI': '10.25646/7170', 'article-title': 'Disease severity of the first COVID-19 wave in Germany using reporting ' 'data from the national notification system', 'volume': '5', 'author': 'Schilling', 'year': '2020', 'journal-title': 'Journal of Health Monitoring'}, { 'key': '10.1002/14651858.CD014962-BIB0171|cit171', 'unstructured': 'Schünemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: ' 'Completing ‘Summary of findings’ tables and grading the certainty of the ' 'evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page ' 'MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of ' 'Interventions Version 6.2 (updated February 2021). Cochrane, 2021 ' 'Available from training.cochrane.org/handbook'}, { 'key': '10.1002/14651858.CD014962-BIB0172|cit172', 'doi-asserted-by': 'publisher', 'DOI': '10.3201/eid2708.211145', 'article-title': 'Delayed antibody and T-cell response to BNT162b2 vaccination in the ' 'elderly, Germany', 'volume': '27 (early relea', 'author': 'Schwarz', 'journal-title': 'Emerging Infectious Diseases'}, { 'issue': '396', 'key': '10.1002/14651858.CD014962-BIB0173|cit173', 'doi-asserted-by': 'publisher', 'first-page': 'eaal3653', 'DOI': '10.1126/scitranslmed.aal3653', 'article-title': 'Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic ' 'coronaviruses', 'volume': '9', 'author': 'Sheahan', 'year': '2017', 'journal-title': 'Science Translational Medicine'}, { 'issue': '1', 'key': '10.1002/14651858.CD014962-BIB0174|cit174', 'doi-asserted-by': 'publisher', 'first-page': '222', 'DOI': '10.1038/s41467-019-13940-6', 'article-title': 'Comparative therapeutic efficacy of remdesivir and combination ' 'lopinavir, ritonavir and interferon beta against MERS-CoV', 'volume': '11', 'author': 'Sheahan', 'year': '2020', 'journal-title': 'Nature Communications'}, { 'issue': '5', 'key': '10.1002/14651858.CD014962-BIB0175|cit175', 'doi-asserted-by': 'publisher', 'first-page': '1648', 'DOI': '10.1021/acs.jmedchem.6b01594', 'article-title': 'Discovery and synthesis of a phosphoramidate prodrug of a ' 'pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the ' 'treatment of ebola and emerging viruses', 'volume': '60', 'author': 'Siegel', 'year': '2017', 'journal-title': 'Journal of Medicinal Chemistry'}, { 'key': '10.1002/14651858.CD014962-BIB0176|cit176', 'doi-asserted-by': 'publisher', 'first-page': 'm2980', 'DOI': '10.1136/bmj.m2980', 'article-title': 'Drug treatments for COVID-19: living systematic review and network ' 'meta-analysis', 'volume': '370', 'author': 'Siemieniuk', 'year': '2020', 'journal-title': 'BMJ'}, { 'key': '10.1002/14651858.CD014962-BIB0177|cit177', 'doi-asserted-by': 'publisher', 'first-page': '124', 'DOI': '10.1016/j.jclinepi.2019.10.015', 'article-title': 'GRADE guidelines 27: how to calculate absolute effects for ' 'time-to-event outcomes in summary of findings tables and evidence ' 'profiles', 'volume': '118', 'author': 'Skoetz', 'year': '2020', 'journal-title': 'Journal of Clinical Epidemiology'}, { 'key': '10.1002/14651858.CD014962-BIB0178|cit178', 'doi-asserted-by': 'publisher', 'first-page': 'l4898', 'DOI': '10.1136/bmj.l4898', 'article-title': 'RoB 2: a revised tool for assessing risk of bias in randomised trials', 'volume': '366', 'author': 'Sterne', 'year': '2019', 'journal-title': 'BMJ'}, { 'issue': '2', 'key': '10.1002/14651858.CD014962-BIB0179|cit179', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/14651858.CD013665.pub2', 'article-title': 'Signs and symptoms to determine if a patient presenting in primary care ' 'or hospital outpatient settings has COVID-19 disease', 'author': 'Struyf', 'year': '2021', 'journal-title': 'Cochrane Database of Systematic Reviews'}, { 'issue': '4', 'key': '10.1002/14651858.CD014962-BIB0180|cit180', 'doi-asserted-by': 'publisher', 'first-page': '326', 'DOI': '10.3390/v11040326', 'article-title': 'Mechanism of inhibition of ebola virus RNA-dependent RNA polymerase by ' 'remdesivir', 'volume': '11', 'author': 'Tchesnokov', 'year': '2019', 'journal-title': 'Viruses'}, { 'key': '10.1002/14651858.CD014962-BIB0181|cit181', 'doi-asserted-by': 'crossref', 'first-page': '16', 'DOI': '10.1186/1745-6215-8-16', 'article-title': 'Practical methods for incorporating summary time-to-event data into ' 'meta-analysis', 'volume': '8', 'author': 'Tierney', 'year': '2007', 'journal-title': 'Trials'}, { 'key': '10.1002/14651858.CD014962-BIB0182|cit182', 'doi-asserted-by': 'publisher', 'first-page': '3', 'DOI': '10.25646/7111', 'article-title': 'Higher lethality and long duration of ventilation distinguish COVID-19 ' 'from severe respiratory tract infections in influenza waves.', 'volume': '41', 'author': 'Tolksdorf', 'year': '2020', 'journal-title': 'Epidemiologisches Bulletin'}, { 'key': '10.1002/14651858.CD014962-BIB0183|cit183', 'doi-asserted-by': 'publisher', 'first-page': '43', 'DOI': '10.1016/j.amsu.2020.12.051', 'article-title': 'Remdesivir therapy in patients with COVID-19: a systematic review and ' 'meta-analysis of randomised controlled trials', 'volume': '62', 'author': 'Vegivinti', 'year': '2021', 'journal-title': 'Annals of Medicine and Surgery'}, { 'issue': '3', 'key': '10.1002/14651858.CD014962-BIB0184|cit184', 'doi-asserted-by': 'publisher', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Research'}, { 'issue': '7594', 'key': '10.1002/14651858.CD014962-BIB0185|cit185', 'doi-asserted-by': 'publisher', 'first-page': '381', 'DOI': '10.1038/nature17180', 'article-title': 'Therapeutic efficacy of the small molecule GS-5734 against ebola virus ' 'in rhesus monkeys', 'volume': '531', 'author': 'Warren', 'year': '2016', 'journal-title': 'Nature'}, { 'key': '10.1002/14651858.CD014962-BIB0186|cit186', 'doi-asserted-by': 'publisher', 'first-page': '200384', 'DOI': '10.1183/16000617.0384-2020', 'article-title': 'Current evidence for COVID-19 therapies: a systematic literature review', 'volume': '30', 'author': 'Welte', 'year': '2021', 'journal-title': 'European Respiratory Review'}, { 'key': '10.1002/14651858.CD014962-BIB0187|cit187', 'unstructured': 'World Health Organization Cumulative number of reported probable cases ' 'of SARS www.who.int/csr/sars/country/2003_07_11/en'}, { 'key': '10.1002/14651858.CD014962-BIB0188|cit188', 'unstructured': 'World Health Organization Middle East respiratory syndrome coronavirus ' '(MERSCoV) www.who.int/emergencies/mers-cov/en'}, { 'key': '10.1002/14651858.CD014962-BIB0189|cit189', 'unstructured': "World Health Organization Timeline: WHO's COVID-19 response " 'www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline'}, { 'key': '10.1002/14651858.CD014962-BIB0190|cit190', 'unstructured': 'World Health Organization Estimating mortality from COVID-19 - ' 'scientific brief ' 'www.who.int/publications/i/item/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1'}, { 'key': '10.1002/14651858.CD014962-BIB0191|cit191', 'unstructured': 'World Health Organization Report of the WHO-China joint mission on ' 'coronavirus disease 2019 (COVID-19) ' 'www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report'}, { 'issue': '8', 'key': '10.1002/14651858.CD014962-BIB0192|cit192', 'doi-asserted-by': 'publisher', 'first-page': 'e192', 'DOI': '10.1016/S1473-3099(20)30483-7', 'article-title': 'A minimal common outcome measure set for COVID-19 clinical research', 'volume': '20', 'author': 'WHO Working Group on the Clinical Characterisation and Management of COVID-19 ' 'infection', 'year': '2020', 'journal-title': 'Lancet Infectious Diseases'}, { 'key': '10.1002/14651858.CD014962-BIB0193|cit193', 'unstructured': 'World Health Organization SARS-CoV-2 mink-associated variant strain - ' 'Denmark ' 'www.who.int/csr/don/06-november-2020-mink-associated-sars-cov2-denmark/en'}, { 'key': '10.1002/14651858.CD014962-BIB0194|cit194', 'unstructured': 'World Health Organization Therapeutics and COVID-19: living guideline ' 'www.who.int/publications/i/item/therapeutics-and-covid-19-living-guideline'}, { 'key': '10.1002/14651858.CD014962-BIB0195|cit195', 'unstructured': 'World Health Organization WHO Coronavirus Disease (COVID-19) Dashboard ' 'covid19.who.int'}, { 'key': '10.1002/14651858.CD014962-BIB0196|cit196', 'unstructured': 'World Health Organization WHO Coronavirus (COVID-19) Dashboard ' 'covid19.who.int/'}, { 'key': '10.1002/14651858.CD014962-BIB0197|cit197', 'unstructured': 'World Health Organization Origins of the SARS-CoV-2 virus ' 'www.who.int/health-topics/coronavirus/origins-of-the-virus'}, { 'key': '10.1002/14651858.CD014962-BIB0198|cit198', 'unstructured': 'World Health Organization Weekly epidemiological update - 16 March 2021 ' 'https://www.who.int/publications/m/item/weekly-epidemiological-update---16-march-2021'}, { 'key': '10.1002/14651858.CD014962-BIB0199|cit199', 'doi-asserted-by': 'publisher', 'first-page': '430', 'DOI': '10.1038/s41586-020-2521-4', 'article-title': 'Factors associated with COVID-19-related death using OpenSAFELY', 'volume': '584', 'author': 'Williamson', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '10.1002/14651858.CD014962-BIB0200|cit200', 'doi-asserted-by': 'publisher', 'first-page': '7824', 'DOI': '10.1038/s41586-020-2423-5', 'article-title': 'Clinical benefit of remdesivir in rhesus macaques infected with ' 'SARS-CoV-2', 'volume': '585', 'author': 'Williamson', 'year': '2020', 'journal-title': 'Nature'}, { 'issue': '2', 'key': '10.1002/14651858.CD014962-BIB0201|cit201', 'doi-asserted-by': 'publisher', 'first-page': '209', 'DOI': '10.7326/M20-5752', 'article-title': 'Remdesivir for adults with COVID-19: a living systematic review for an ' 'American College of Physicians Practice Point', 'volume': '174', 'author': 'Wilt', 'year': '2021', 'journal-title': 'Annals of Internal Medicine'}, { 'issue': '13', 'key': '10.1002/14651858.CD014962-BIB0202|cit202', 'doi-asserted-by': 'publisher', 'first-page': '1239', 'DOI': '10.1001/jama.2020.2648', 'article-title': 'Characteristics of and important lessons from the coronavirus disease ' '2019 (COVID-19) outbreak in China: summary of a report of 72314 cases ' 'from the Chinese Center for Disease Control and Prevention', 'volume': '323', 'author': 'Wu', 'year': '2020', 'journal-title': 'JAMA'}, { 'issue': '6485', 'key': '10.1002/14651858.CD014962-BIB0203|cit203', 'doi-asserted-by': 'publisher', 'first-page': '1444', 'DOI': '10.1126/science.abb2762', 'article-title': 'Structural basis for the recognition of SARS-CoV-2 by full-length human ' 'ACE2', 'volume': '367', 'author': 'Yan', 'year': '2020', 'journal-title': 'Science'}, { 'key': '10.1002/14651858.CD014962-BIB0204|cit204', 'doi-asserted-by': 'publisher', 'first-page': '198137', 'DOI': '10.1016/j.virusres.2020.198137', 'article-title': 'Effect of remdesivir on patients with COVID-19: a network meta-analysis ' 'of randomised control trials', 'volume': '288', 'author': 'Yokoyama', 'year': '2020', 'journal-title': 'Virus Research'}], 'container-title': 'Cochrane Database of Systematic Reviews', 'original-title': [], 'language': 'en', 'deposited': { 'date-parts': [[2022, 5, 30]], 'date-time': '2022-05-30T09:41:37Z', 'timestamp': 1653903697000}, 'score': 1, 'resource': {'primary': {'URL': 'http://doi.wiley.com/10.1002/14651858.CD014962'}}, 'subtitle': [], 'editor': [{'name': 'Cochrane Haematology Group', 'sequence': 'first', 'affiliation': []}], 'short-title': [], 'issued': {'date-parts': [[2021, 8, 5]]}, 'references-count': 204, 'journal-issue': {'issue': '8', 'published-online': {'date-parts': [[2021, 8]]}}, 'URL': 'http://dx.doi.org/10.1002/14651858.CD014962', 'relation': {}, 'ISSN': ['1465-1858'], 'subject': [], 'published': {'date-parts': [[2021, 8, 5]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit